Prevalence and clinical correlates of restless legs syndrome among psychogeriatric patients

International Journal of Geriatric Psychiatry

Volumn 26, Issue 12, 2011, Pages 1252-1259

  Agüera Ortiz, Luis ^a,b,c   Perez, M Isabel Ramos García ^c,d   Osorio, Ricardo S ^c,e   Sacks, Hayley ^e   Palomo, Tomás ^a,b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

depression; old age; prevalence; psychiatric outpatients; restless legs syndrome; underdiagnosis

Indexed keywords

ANTACID AGENT; ANTIHYPERTENSIVE AGENT; ARIPIPRAZOLE; CLOMETHIAZOLE; CLORAZEPATE; ESCITALOPRAM; LORAZEPAM; LORMETAZEPAM; MIRTAZAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OLANZAPINE; PAROXETINE; PIMOZIDE; SERTRALINE; SULPIRIDE; TRAZODONE; VENLAFAXINE; ZOLPIDEM;

AGED; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GERONTOPSYCHIATRY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT; PREVALENCE; RESTLESS LEGS SYNDROME; RISK FACTOR;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PREVALENCE; RESTLESS LEGS SYNDROME; RISK FACTORS;

EID: 80855143602     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2674     Document Type: Article

References (33)

1. Allen RP, Picchietti D, Hening WA, et al,. 2003. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4: 101-119. (Pubitemid 36527231)
2. Baos Vicente V, Grandas Perez F, Kulisevsky Bojarski J, et al,. 2009. Restless legs syndrome: detection, diagnosis, impact on health and utilization of health care resources. Rev Clin Esp 209: 371-381.
3. Brown LK, Dedrick DL, Doggett JW, Guido PS., 2005. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med 6: 443-450. (Pubitemid 41245367)
4. Celle S, Roche F, Kerleroux J, et al,. 2010. Prevalence and clinical correlates of restless legs syndrome in an elderly French population: the synapse study. J Gerontol A Biol Sci Med Sci 65: 167-173. Epub 2009 Nov 13.
5. Christensen AF, Poulsen J, Nielsen CT, et al,. 2006. Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study. Acta Psychiatr Scand 113: 148-153. (Pubitemid 43340909)
6. Cohrs S, Rodenbeck A, Hornyak M, Kunz D., 2008. Restless legs syndrome, periodic limb movements, and psychopharmacology. Nervenarzt 79: 1263-1264, 1266-1272.
7. Ekbom KA., 1945. Restless legs: a clinical study. Acta Med Scand 158: 1-122.
8. Ferri R, Lanuzza B, Cosentino FI, et al,. 2007. A single question for the rapid screening of restless legs syndrome in the neurological clinical practice. Eur J Neurol 14: 1016-1021. (Pubitemid 47300775)
9. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K., 2006. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 10: 153-167. (Pubitemid 43817594)
10. Gorman CA, Dyck PJ, Pearson JS., 1965. Symptom of restless legs. Arch Intern Med 115: 155-160.
11. Hening W, Walters AS, Allen RP, et al,. 2004. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 5: 237-246. (Pubitemid 38684217)
12. Kim SW, Shin IS, Kim JM, et al,. 2005. Bupropion may improve restless legs syndrome: a report of three cases. Clin Neuropharmacol 28: 298-301.
13. Kim SW, Shin IS, Kim JM, et al,. 2008. Factors potentiating the risk of mirtazapine-associated restless legs syndrome. Hum Psychopharmacol 23: 615-620.
14. Lee HB, Hening WA, Allen RP, et al,. 2008. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci 20: 101-105. (Pubitemid 351295036)
15. Markkula J, Lauerma H., 1997. Mianserin and restless legs. Int Clin Psychopharmacol 12: 53-58. (Pubitemid 27171197)
16. McLean AJ., 2004. The use of the dopamine-receptor partial agonist aripiprazole in the treatment of restless legs syndrome. Sleep 27: 1022. (Pubitemid 39095737)
17. Oboler SK, Prochazka AV, Meyer TJ., 1991. Leg symptoms in outpatient veterans. West J Med 155: 256-2569.
18. Ondo WG, Vuong KD, Jankovic J., 2002. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 59: 421-424. (Pubitemid 34208151)
19. Phillips B, Young T, Finn L, et al,. 2000. Epidemiology of restless legs symptoms in adults. Arch Intern Med 160: 2137-2141. (Pubitemid 30482720)
20. Picchietti D, Winkelman JW., 2005. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 28: 891-898. (Pubitemid 40993722)
21. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K., 2000. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 54: 1064-1068. (Pubitemid 30151846)
22. Rottach KG, Schaner BM, Kirch MH, et al,. 2008. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res 43: 70-75. Epub 2008 May 12.
23. Saletu M, Anderer P, Saletu B, et al,. 2002. EEG mapping in patients with restless legs syndrome as compared with normal controls. Psychiatry Res 115: 49-61. (Pubitemid 34880098)
24. Sanz-Fuentenebro FJ, Huidobro A, Tejadas-Rivas A., 1996. Restless legs syndrome and paroxetine. Acta Psychiatr Scand 94: 482-484. (Pubitemid 27028815)
25. Schlesinger I, Erikh I, Avizohar O, Sprecher E, Yarnitsky D., 2009. Cardiovascular risk factors in restless legs syndrome. Mov Disord 24: 1587-1592.
26. Sevim S, Dogu O, Kaleagasi H, et al,. 2004. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatr 75: 226-230. (Pubitemid 38183528)
27. Sohn IK, Kim IY, Hahm W, et al,. 2008. Is there any difference of incidente of the restless legs síndrome between antipsychotics. Eur Neuropsychopharmacol 18: S416.
28. Spoormaker VI, van den Bout J., 2005. Depression and anxiety complaints; relations with sleep disturbances. Eur Psychiatry 20: 243-245. (Pubitemid 40779634)
29. Trenkwalder C, Hening WA, Montagna P, et al,. 2008. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 23: 2267-2302.
30. Trotti LM, Bhadriraju S, Rye DB., 2008. An update on the pathophysiology and genetics of restless legs syndrome. Curr Neurol Neurosci Rep 8: 281-287.
31. Virit O, Selek S, Savas HA, Kokacya H., 2009. Improvement of restless legs syndrome and trichotillomania with aripiprazole. J Clin Pharm Ther 34: 723-725.
32. Walters AS., 1995. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 10: 634-642.
33. Winkelmann J, Prager M, Lieb R, et al,. 2005. " Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome. J Neurol 252: 67-71. (Pubitemid 40179020)